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Objectives: Gait and mobility problems are difficult to treat in people with Parkinson’s disease. The
Rehabilitation in Parkinson’s Disease: Strategies for Cueing (RESCUE) trial investigated the effects of a home
physiotherapy programme based on rhythmical cueing on gait and gait-related activity.
Methods: A single-blind randomised crossover trial was set up, including 153 patients with Parkinson’s
disease aged between 41 and 80 years and in Hoehn and Yahr stage II–IV. Subjects allocated to early
intervention (n = 76) received a 3-week home cueing programme using a prototype cueing device, followed
by 3 weeks without training. Patients allocated to late intervention (n = 77) underwent the same intervention
and control period in reverse order. After the initial 6 weeks, both groups had a 6-week follow-up without
training. Posture and gait scores (PG scores) measured at 3, 6 and 12 weeks by blinded testers were the
primary outcome measure. Secondary outcomes included specific measures on gait, freezing and balance,
functional activities, quality of life and carer strain.
Results: Small but significant improvements were found after intervention of 4.2% on the PG scores
(p = 0.005). Severity of freezing was reduced by 5.5% in freezers only (p = 0.007). Gait speed (p = 0.005),
step length (p,0.001) and timed balance tests (p = 0.003) improved in the full cohort. Other than a greater
confidence to carry out functional activities (Falls Efficacy Scale, p = 0.04), no carry-over effects were
observed in functional and quality of life domains. Effects of intervention had reduced considerably at 6-week
follow-up.
Conclusions: Cueing training in the home has specific effects on gait, freezing and balance. The decline in
effectiveness of intervention effects underscores the need for permanent cueing devices and follow-up
treatment. Cueing training may be a useful therapeutic adjunct to the overall management of gait disturbance
in Parkinson’s disease.
I
n neurological patients, Parkinson’s disease is the most
common disorder leading to gait disturbance and falls.1
Despite advances in pharmacological treatments and surgical
techniques, gait and balance deficits still persist and are
associated with loss of independence, immobility and high
cost for healthcare systems.2 Therefore, the development of
rehabilitation approaches that work in conjunction with
current treatment is important to manage these problems.
Recent systematic reviews concluded that evidence available
was insufficient to support or refute the efficacy of physiother-
apy in Parkinson’s disease or to support the use of one form of
physiotherapy over another.3 4 Some studies had methodologi-
cal problems. However, reviewers did comment that the efficacy
of physiotherapy was improved by the addition of cueing
techniques. Cueing is defined as using external temporal or
spatial stimuli to facilitate movement (gait) initiation and
continuation. Recent reviews on cueing suggest that it can have
an immediate and powerful effect on gait performance in
people with Parkinson’s disease, indicating improvements in
walking speed, step length and step frequency.5 6 The influence
of cueing has mainly been studied in single-session experi-
ments in laboratory settings.7–11 Results show a short-term
correction of gait and gait initiation, and suggest that carry-over
to uncued performance and its generalisation to activities of
daily living (ADL) is limited. Using cues in a therapeutic setting
is more complex, as the ‘‘modality’’ of cue delivery (visual,
auditory or somatosensory) and the cue ‘‘parameter’’ selected
for movement correction (frequency or size of step) have to be
adapted to the needs of the patient. Apart from two limited
studies on the retention effects of cues, to date no work has
evaluated the clinical application and prolonged training effects
of cues in the home to improve walking in a functional
context.12 13 Furthermore, improved mobility with cues may
have an adverse effect by distracting attention, increasing the
risk of falling.14 15
The primary objective of this study was to investigate the
efficacy of a home-based cueing programme on parameters of
gait, gait-related activity and health-related quality of life in
people with Parkinson’s disease. We hypothesised that a 3-
week period of home-based cueing training would result in
measurable improvements of selected gait parameters immedi-
ately after treatment, but that these effects might decrease after
6 weeks without cueing.
METHODS
Study population
We recruited 153 patients with idiopathic Parkinson’s disease
from three European centres: Northumbria University,
Newcastle upon Tyne (UK); Katholieke Universiteit Leuven,
Leuven (Belgium); and the Vrije Universiteit Medical Centre
Amsterdam, Amsterdam (The Netherlands). The study was
approved by the ethics committee of each participating centre.
All patients gave informed written consent to the study.
Eligibility criteria were: showing mild to severe gait disturbance
with score .1 on the Unified Parkinson’s Disease Rating Scale
Abbreviations: ADL, activities of daily living; ICC, intraclass correlation
coefficient; PG score, posture and gait score; RESCUE, Rehabilitation in
Parkinson’s Disease: Strategies for Cueing; UPDRS, Unified Parkinson’s
Disease Rating Scale
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(UPDRS; item 29)16; diagnosis of idiopathic Parkinson’s disease
(defined by the UK Brain Bank Criteria)17; stable drug usage;
Hoehn and Yahr stage II–IV; and age 18–80 years. Patients
were excluded if they had undergone deep brain stimulation or
other stereotactic neurosurgery; had cognitive impairment
(Mini Mental State Examination Scores ,24)18; had disorders
interfering with participation in cueing training, including
neurological (stroke, multiple sclerosis, tumour), cardiopul-
monary (chronic obstructive disorders, angina pectoris) and
orthopaedic (osteoarthritis, rheumatoid arthritis and back
pain) conditions; had unpredictable and longlasting off periods
(score 1 on item 37 and score .2 on item 39 of the UPDRS)16;
and had participated in a physiotherapy programme 2 months
before starting the trial.
Design and procedures
The present study was a single-blind, randomised, clinical trial
with a crossover design with no wash-out period. The choice of
design was based on previous evidence of the short-lasting
effects of cueing,5 6 the advantage of providing treatment for all
patients, and increasing the statistical power within the
constraints of research funding. In each centre, patients were
randomly allocated in permuted blocks of six to an early or late
intervention group by an independent investigator not involved
in data analysis. Allocation was concealed by the use of opaque
sealed envelopes. The early group received a cueing programme
delivered in nine treatment sessions for 30 min over 3 weeks,
immediately followed by 3 weeks in which no training was
received. Subjects in the late group were put on a 3-week
waiting list immediately followed by 3 weeks of cueing
training. Both treatment arms underwent a follow-up period
of 6 weeks without training. Medical treatment continued
unchanged throughout the study. Before the Rehabilitation in
Parkinson’s Disease: Strategies for Cueing (RESCUE) trial,
therapists and testers underwent separate training sessions
lasting a full week to standardise the procedures in all centres.
Intervention
Cueing training was delivered in the home by one therapist at
each location. A prototype cueing device, specifically developed for
the study, provided three rhythmical cueing modalities: (1)
auditory (a beep delivered through an earpiece); (2) visual (light
flashes delivered through a light-emitting diode attached to a pair
of glasses); and (3) somatosensory (pulsed vibrations delivered by
a miniature cylinder worn under a wristband). Patients tried all
cueing modalities in the first week, but trained with their
preferred modality. By correcting the temporal aspects of gait,
cueing training aimed to improve step length and walking speed,
prevent freezing episodes and improve balance.
Cued practice was applied during a variety of tasks and
environmental situations and consisted of the following
components: gait initiation and termination,10 11 heel strike
and push-off, sideways and backwards stepping, walking while
dual tasking,19 and walking over various surfaces and long
distances.8 For ‘‘freezers’’, cues were applied to facilitate
continuation of gait during turns and manoeuvres in tight
places and doorways. On the basis of previous experiments
undertaken by the RESCUE consortium19–22 and the literature,5 6
evidence-based cueing guidelines were drawn up, specifying
the cueing parameters and instructions for different profiles of
patients (available on CD-Rom at http://www.rescueproject.org/
). Cues were generally delivered at patients’ preferred frequency
(determined for indoor and outdoor environments) and
adjusted to increase step length and walking speed, depending
on the aims of therapy. In case patients had freezing, cueing
frequency was started at the preferred rhythm and adjusted to
lower rhythms to avoid hastened stepping if needed.22 Patients
were mainly instructed to match their heel strike with the
cueing rhythm and keep on stepping through turns or during
other manoeuvres. Specific instructions to maintain or extend
step length or heel strike with every cue were added if and
when required. Therapists recorded the content and amount of
therapy in a diary in 15-min units.
Outcome measures
As this study wanted to measure the training effects and not
the immediate effects of cueing, outcome measures were tested
without the cueing device. Most outcomes described below
were tested for reliability and validity at home before the trial
by three testers and during two consecutive visits. Part of this
study, including the full method, was published elsewhere.23 As
the RESCUE trial included repeated measures performed by the
same tester, the intraclass correlation coefficients (ICC) for
within raters of each outcome are described as below.
1. The primary outcome measure was the posture and gait
(PG) score, a composite score of gait and balance UPDRS items
(13–15 and 29–30), reflecting the main aims of cueing training
(ICC = 0.79).
2. To explore the specific effects of cueing training, secondary
outcome measures consisted of the following:
a. Gait and balance measures: 10-m test of walking at the
person’s preferred walking speed, using a stopwatch to
calculate gait speed (m/s; ICC = 0.81), step length (m) and
step frequency (steps/min); functional reach24 (ICC = 0.74);
timed single leg and tandem stance until subjects reached a
maximum of 30 s; Freezing of Gait Questionnaire25
(ICC = 0.84); and Timed Get Up and Go Test2 6
(ICC = 0.88). Timed walking and Get Up and Go tests were
standardised for each patient’s home.
b. Activity measures: Nottingham Extended Activities of Daily
Living Index27 (ICC = 0.93) and Falls Efficacy Scale28
(ICC = 0.88).
c. Participation measures: Parkinson’s Disease Questionnaire-
3929 (ICC = 0.79) and Carer Strain Index30 (ICC = 0.85).
A falls diary was left in the patient’s home during the trial
period to indicate the number of falls as a measure of possible
adverse cueing effects. A dichotomised score was derived
(falls = 1 or no falls = 0) at crossover and at the end of therapy
from the recorded number of falls during the previous 3-week
periods and at follow-up for the previous 6 weeks. At test 1, the
dichotomised score was calculated from the number of falls
during the previous 3 months.
Descriptive measures included the Mini Mental State
Examination,13 the Brixton Test31 for executive function, and
the Hospital Anxiety and Depression Scale.32
Assessment protocol
All outcome measures were assessed immediately before
randomisation (test 1) and at 3 (test 2), 6 (test 3), and
12 weeks (test 4). One trained tester at each centre, not
involved in training and blinded to group allocation, performed
all assessments in the patient’s home. Each patient was
assessed at the same time of day in the on phase, approximately
1 h after drug intake, to control for variations due to the drug
cycle. The order of tests was randomised for each patient.
Testers verified that patients had taken their drugs, and the
efficacy of drugs was checked at each assessment.
Statistical analysis
Power analysis before the trial indicated that 150 patients were
required for a 10% change relative to baseline values on the PG
score (0.6 points) with a power of 80% and a critical value of 5%
for statistical significance, allowing a drop-out of 10%.
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The success of blinding and randomisation procedures was
explored by comparing early and late groups using Wilcoxon
tests Mann–Whitney U tests, x2 tests and unpaired t tests.
Exploratory analysis showed carry-over effects of treatment in
the control period (test 32test 2) in the early group. Hence,
intervention effects were estimated using the first three assess-
ments (tests 1–3), with multiple linear regression models
accounting for repeated measures. Where appropriate, a linear,
logistic or Cox regression model was fitted for each outcome with
PROC MIXED and PROC GENMOD in SAS (V.8.2). In each model
the same predictors were adopted, including indicators to
represent time, intervention and carry-over. A logistic regression
model with generalised estimating equations evaluated the effect
of intervention on the risk of falling. A Cox regression model with
frailty term verified the effect of intervention on the hazard of
failing the timed balance tests (inability to remain standing for a
maximum of 30 s), using the coxph function in Splus 2000. To
explore whether cueing had an effect on movements that were not
targeted by training, upper limb repetitive movement scores
(UPDRS items 23–25) were analysed.
Change at follow-up was assessed by comparing the change
between tests 3 and 4 using a model with two factors (time and
group) fitted to the outcomes of tests 1–4 for early and late
groups taken together. For continuous outcomes, a trivariate
normal distribution for error components was assumed. Data
were transformed where necessary to meet normality assump-
tions, and baseline values were reported as medians and
interquartile ranges. Two-tailed analysis was performed on all
tests with a significance level of 5%. Given the exploratory
nature of the secondary outcomes analysis, no Bonferroni
correction was applied. Intervention effects are reported as b
estimates and standard errors (SE) for the linear regression
models. Odds and hazard ratios (OR and HR; = exp(b)) with
95% confidence intervals are presented for the logistic and Cox
regression models.
The statistical models adopted in this study were based on the
assumption that missing values occur randomly and used the
remaining information even if missing values were occasionally
present. Missing values occurred in 1.7% of all outcomes over the
four time points and 1.3% over the three time points. As all
patients received treatment and only one drop-out occurred, an
‘‘intention-to-treat’’ analysis was not carried out.
RESULTS
Trial profi le
The trial flow chart (fig 1) shows that of 289 potential
candidates, 153 patients (53%) were eligible for inclusion into
the study. Patients were mostly excluded because of insufficient
impairment of gait (n = 44), comorbidity (n = 25), deep brain
stimulation (n = 15) and an inability to commit the time
needed (n = 15). Suitable patients were randomly allocated to
the early (n = 76) or late intervention group (n = 77). One
patient dropped out 3 weeks after randomisation, owing to a
necessary change of drug. In total, 605 (99%) of the planned
612 measurements were performed. Drug intake remained
stable throughout the trial. Comparison between the observers’
guess of allocation (early or late) and the actual patient
assignment indicated that the blinding procedure was success-
ful, as 56.1% (n = 87) was allocated correctly and 43.1%
(n = 66) incorrectly (x2 = 2.94, p = 0.09).
Comparison of early and late intervention
Patients received equal amounts of therapy in the early
(271.8 min) and late groups (270.4 min) (t statistic = 0.27;
p = 0.79).
No important differences were found between the clinical
profiles of the two intervention groups (table 1). Most patients
had mild to moderate disease severity as 46.4% of patients
(n = 71) were in Hoehn and Yahr stage II, 41.8% (n = 64) in
stage III and 11.8% (n = 18) in stage IV. Both early and late
groups included similar numbers of freezers defined as having
at least weekly freezing episodes (n = 31, 20.3% in early; and
n = 32, 20.9% in late), as defined by a score .1 on item 3 of the
Freezing of Gait Questionnaire. Table 2 shows the median and
interquartile ranges of all outcomes at tests 1–4. No significant
group differences were found for primary and secondary
outcomes at test 1, confirming the success of the randomisation
procedure. Table 2 shows that 41% in the early and 39% in the
late group reported at least one episode of falling in the
3 months before the onset of trial.
Treatment effects
Table 3 shows the estimated intervention effects corrected for
time and carry-over. The primary outcome, the PG score,
improved by 4.2% after intervention (p = 0.005). As for the
secondary outcomes, gait speed (p = 0.005) and step length
(p,0.001) improved by 5 cm/s and 4 cm, respectively. No
significant change in step frequency was observed (p = 0.08).
The Functional Reach test did not show an intervention effect
(p = 0.18). However, the clustered tandem and one leg standing
tests showed that the chance of failing these tests was
decreased by 36% after intervention (HR 0.64; 95% confidence
interval (CI) 0.48 to 0.87; p = 0.003). The Timed Get Up and Go
test did not show improvement after intervention. As for the
severity of freezing, the Freezing of Gait Questionnaire scores
were not significantly affected by cueing therapy (p = 0.25)
after transformation. Data showed a bimodal distribution
indicating a group with low scores (non-freezers) and a group
with high scores (freezers). When the Freezing of Gait
Questionnaire scores were re-analysed on freezers only
(n = 63), defined as having at least a weekly freezing frequency,
a significant reduction of 5.5% of freezing severity was found
(mean (SE) b estimate =21.33 (0.48), p = 0.007).
Table 3 presents intervention effects that are smaller
compared with the change in median values before and after
intervention for the early and late groups in table 2 as a result
of the statistical control for time and carry-over effects—for
example, the PG score improved from a median of 6 to 4 after
treatment, suggesting a 10% rather than a 4.2% change of the
scoring range. Overall, carry-over effects were only significant
for step length in the early group at test 3 (p = 0.014). Time
effects showed significant improvements for the PG score
(p = 0.03), gait speed (p = 0.04) and the TGUG (p = 0.004).
For the secondary outcomes in the activity domain, improve-
ments were found on the Falls Efficacy Scale (p = 0.03),
indicating that patients felt more confident during gait-related
activities. ADL function as measured by the Nottingham
Extended Activities of Daily Living Index was not significantly
altered (p = 0.07). The Parkinson’s Disease Questionnaire-39
scores (p = 0.23) and the Carer Strain Index were not
significantly changed after intervention (p = 0.14). The general-
ised estimating equations model showed no significant increase
or decrease in the probability of falling as a result of treatment
(OR 1.4; 95% CI 0.63 to 3.1; p = 0.4). Separate analysis of the
upper limb repetitive movement scores of the UPDRS (III)
showed no significant treatment effect (b 21.1 (0.62),
p = 0.08). Most patients (n = 95, 67%) chose auditory cueing
as their preferred cueing modality, whereas 57 patients (n = 58,
33%) favoured somatosensory cueing.
Follow-up (test 4 2 test 3)
Table 3 also shows the change at follow-up. Most intervention
effects in the gait and balance domains declined significantly
from 6 to 12 weeks. Secondary outcomes at activity and
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participation levels also tended to decline at test 4, a pattern
that was significant for the Falls Efficacy Scale. The chance of
failing the balance tests at test 4 was increased as compared
with test 3 (HR 1.12; 95% CI 0.96 to 1.32), but this difference
was not significant (p = 0.15). Table 2 shows that more patients
reported a fall at test 4 compared with test 3 but this may reflect
the fact that at test 4 a period of 6 weeks was assessed, as
opposed to 3 weeks at test 3.
DISCUSSION
This is the first large-scale randomised clinical trial investigat-
ing the effects of a cueing training programme delivered at
home using a multimodality cueing device. The main findings
indicate that nine sessions of cueing training demonstrated
considerable improvement in gait and gait-related mobility in
people with Parkinson’s disease, but that these effects were
small and specific. The cueing method was widely accepted and
well tolerated in a wide range of patients, ranging from Hoehn
and Yahr stages II to IV, as evidenced by only one drop-out.
The present findings showed that a period of training with
cues in the homes of people with Parkinson’s disease resulted
in improvement of gait immediately after intervention. We
found a significant increase in walking speed and step
amplitude accompanied by a tendency to reduce step frequency.
This finding is in agreement with earlier work, showing that
the potential to generate a more normal gait pattern can be
tapped in Parkinson’s disease.7 When looking at freezers
Figure 1 Trial flow chart.
Table 1 Comparison between early and late allocation
groups
Early (n = 76)
median (IR: Q1–Q3)
Late (n = 77)
median (IR: Q1–Q3)
Demography
M/F* 48/28 40/37 0.16
Age 67.5 (61.5–72) 69 (62.5–73) 0.7
PD characteristics
Disease duration 7 (4–11) 8 (4–12) 0.59
H&Y (on) 2.5 (2.5–3) 3 (2.5–3) 0.56
H&Y II/III/IV* 39/29/8 32/35/10 0.48
Freezers/non-
freezers*
31/45 32/45 0.92
Clinical data
UPDRS-total (on) 54 (46–65.5) 56 (49–63) 0.62
UPDRS I (on) 4 (2–5) 3 (2–4) 0.1
UPDRS II (on) 16 (12–19.5) 16 (12–20) 0.67
UPDRS III (on) 31 (25–37) 34 (28–41) 0.32
UPDRS IV (on) 3 (1–5) 2 (1–5) 0.43
Levodopa (mg) 500 (300–700) 350 (200–550) 0.07
MMSE 28.5 (27–30) 29 (27–30) 0.99
Brixton 4 (2–6) 4.0 (2–6) 0.45
HADS anxiety 6.5 (4–10) 6 (4–10) 0.97
HADS depression 7.5 (5–10) 6 (4.5–9) 0.45
HADS, Hospital Anxiety and Depression Scale; H&Y (on), Hoehn and Yahr
stages during on; H&Y II/III/IV, Hoehn and Yahr stages II, II, IV during on;
IR, interquartile range; M/F, male/female; MMSE, Mini Mental State
Examination; PD, Parkinson’s disease; UPDRS, Unified Parkinson’s Disease
Rating Scale part I, II, III, IV and total score.
*Expressed as number of patients and p value based on x2 test.
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separately, a significant change on the Freezing of Gait
Questionnaire after intervention was found, signifying a
reduction of freezing severity. This is an important finding, as
freezing is particularly resistant to drug treatment and often
associated with falling.33 This result contradicts earlier work in
which freezers were provided with a metronome for 1 week at
home without clear benefits.34 In contrast, during the RESCUE
trial, cueing therapy was provided by therapists, who used
specific guidelines to set the cueing frequency to the needs of
freezers, and instructed patients on how to prevent and
overcome freezing in their daily environment for a 3-week
period.22
Increased rates of falls in people with Parkinson’s disease are
well documented and have been attributed to preserved
mobility in this population.2 35 We were, therefore, concerned
that any improvements in mobility due to therapeutic cueing
could have resulted in an increased risk of falls. Our results,
however, showed no evidence for this, but rather evidence of
improved balance and increased confidence in the patients that
they would not fall. Given the limited power to detect changes
in fall rates using a fall-diary method over a short time span,
the present results need cautious interpretation.
Subjects were trained for 3 weeks with cues and were
evaluated without wearing the device to see if the effects were
maintained. The present results showed training effects in the
absence of cues, indicating that some degree of motor learning
is preserved in Parkinson’s disease. Whereas most studies
investigated the immediate benefits of cued performance, our
findings confirm the limited evidence available of improved
‘‘uncued’’ performance after training with cues.6 8 12
The effects found in this study can be considered robust and
not attributable to measurement error or learning effects. All
but three outcome measures had established test–re-test
reliability in the home situation23 and the order of testing was
randomised. To estimate the effects of intervention separately
from carry-over and time effects, the statistical analysis
controlled for these factors, providing a conservative estimation
of treatment effects.
The fact that intervention effects were small could reflect a
limitation of cueing training in the home setting. However,
current effects sizes are in line with those observed in recent meta-
analyses on physiotherapy in Parkinson’s disease3 4 and in other
conditions such as stroke.36 37 The limited effects may also be
explained by the relatively short training duration. Training
Table 2 Medians and interquartile ranges of the outcomes in early and late intervention groups at tests 1–4
Test 1
median (Q1–Q3)
Test 2
median (Q1–Q3)
Test 3
median (Q1–Q3)
Test 4
median (Q1–Q3)
Primary outcome
PG score (0–20)
Early 6.0 (4.0–8.0) 4.0 (3.0–7.0) 4.0 (3.0–6.0) 4.0 (3.0–7.0)
Late 7.0 (5.0–8.5) 6.0 (4.0–8.0) 4.0 (3.0–6.0) 5.0 (3.0–7.0)
Secondary outcomes
Walking speed (m/s)
Early 0.86 (0.73–0.98) 0.94 (0.80–1.1) 0.94 (0.80–1.1) 0.92 (0.81–1.1)
Late 0.83 (0.68–0.98) 0.83 (0.72–1) 0.93 (0.77–1.1) 0.94 (0.76–1.1)
Step length (m)
Early 0.51 (0.44–0.58) 0.55 (0.48–0.63) 0.56 (0.47–0.62) 0.54 (0.46–0.60)
Late 0.50 (0.43–0.56) 0.51 (0.43–0.58) 0.55 (0.47–0.62) 0.55 (0.48–0.60)
Step frequency (steps/min)
Early 101.6 (92.5–110) 102 (89.4–108.1) 102.2 (92.5–109.2) 102.2 (95.2–111)
Late 99 (91.6–109.6) 102.5 (94.3–112.6) 101 (94–108.6) 104.2 (97.2–112)
Functional reach (cm)
Early 25.9 (20.9–31) 26.3 (23–30.5) 27.5 (20.3–33) 26.9 (23–31.4)
Late 25.2 (20.2–30.5) 25.5 (19.8–30.7) 28.6 (21.6–34.3) 26.5 (19–31)
Single stance (s)
Early 9 (3.8–20.9) 11.2 (5.3–24.4) 12 (5.5–23.2) 11 (5.2–22.1)
Late 9.1 (3.9–21) 9.5 (3.6–19.3) 14.2 (6.3–24) 12.6 (4.2–21.8)
Tandem stance (s)
Early 22 (9.3–30) 26.7 (14.3–30) 22.0 (11.1–30) 23.1 (10.4–30)
Late 23.1 (8.0–30) 20.7 (8.6–30) 24.6 (11.1–30) 22.1 (10.2–30)
TGUG (s)
Early 13.2 (10.9–17.7) 12.3 (10.8–15) 11.8 (10.7–15.7) 12.2 (11.0–15.6)
Late 13.9 (12.0–17.9) 12.7 (11.1–15.7) 12.1 (10.6–15.1) 12.2 (10.7–15.5)
FOGQ (0–24)
Early 8 (4–14) 8 (3–12) 7 (3–11.5) 7 (3–12.5)
Late 8 (4.5–12) 9 (4–12) 8 (3–11) 8 (4–12)
NEADL (0–66)
Early 41 (32–53.8) 42 (33–51) 42.5 (36.3–53.5) 46 (35.8–53.3)
Late 40 (35–51) 42.5 (23.3–54) 46 (34–51) 43.5 (35–51)
FES (0–130)
Early 85 (65.3–107.8) 91 (71–111) 94 (66–110) 90 (65.5–111.5)
Late 78 (57–99.5) 82 (54–104) 85 (70–108.3) 81 (57.5–105.5)
PDQ-39 (total%)
Early 35.4 (22.7–42.6) 31.3 (22.2–40.9) 30.9 (20–42.3) 34.2 (21.8–40.8)
Late 37.8 (27.6–45.9) 37.2 (25.9–42.7) 32.3 (20.7–41.4) 35.6 (22.8–43.5)
CSI (0–13)
Early 4 (1–5.8) 3 (1–4) 3.0 (1–6) 1 (0–3)
Late 2 (1–5) 4 (1–5.5) 3.0 (0–5) 1.5 (0–3.3)
*Falling (yes/no, % yes)
Early 31/44 (41%) 18/58 (24%) 8/67 (11%) 16/59 (21%)
Late 30/47 (39%) 14/63 (18%) 10/67 (13%) 13/64 (17%)
CSI, Carer Strain Index; FES, Falls Efficacy Scale; FOGQ, Freezing Of Gait Questionnaire; NEADL, Nottingham Extended ADL Index; PDQ-39, Parkinson’s Disease
Questionnaire; PG score, posture and gait score; TGUG, Timed Get Up and Go test.
*Falling: time periods of falls diary at each test period differ (test 1 = 3 months, test 2 = 3 weeks; test 3 = 3 weeks; test 4 = 6 weeks). Figures represent numbers of patients
who fell. One missing value was obtained at test 1 in the early group and at tests 3 and 4 due to drop-out.
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intensity rather than content was found to be a key factor in
stroke research and may be equally crucial in Parkinson’s
disease.37 In this study, training intensity was stipulated by the
maximum number of physiotherapy sessions at home allowed for
reimbursement according to existing healthcare policies. This
raises the question of what the optimal duration and intensity of
cueing training is and how this should be delivered over time.
What actually constitutes clinically relevant results in
rehabilitation of a chronic degenerative disorder is still unclear
at this point. Possibly, the improvements of gait and balance
were too small to carry over to ADL and perceived quality of life.
Alternatively, the narrow focus of the intervention may have
led to specific effects, as we showed that repetitive upper limb
movements were not affected by cueing therapy. Equally, in
other fields of rehabilitation lack of generalisation is a common
feature.36 37
Training effects were not sustained at 6-week follow-up as a
considerable reduction in most outcomes was apparent.
Similarly, Nieuwboer et al38 showed a considerable deterioration
at 12 weeks after training with cues and Thaut et al39 found a
declining slope from 4-week to 6-week follow-up. Other
authors reported negligible reductions at 4–6 weeks after
cueing training.12 40
The effect of placebo effects as a result of increased attention
during therapy was not controlled for, which is a limitation of
this study. Although the specificity of the results argues against
a general effect of increased attention, effects of gait-related
attention rather than cueing cannot be ruled out. Previously, it
was shown that gait training with auditory cues was more
effective than training without cues and no training.8
Lack of Bonferroni correction and the fact that at tests 3 and 4
testers were aware of patients having received therapy, inherent to
a repeated-measures design, warrant careful interpretation of the
results. However, testers were not unblinded to treatment
allocation at any time point. The findings of this study cannot
be generalised to people with Parkinson’s disease who have
significant cognitive decline and other comorbidities. Especially in
the later disease stages, cues may overburden cognitive resources
and increase fall risk.14 Future work should focus on determining
such at-risk patients. Equally, the possibility that cues may
actually reduce attentional cost in patients who are not at risk
requires further investigation. Recently, we found that during
cued performance of dual tasks, gait parameters improved rather
than deteriorated.19 Future studies, assessing cueing effects over a
longer period of time, will be able to determine whether
habituation occurs to the stimulus of the cue and verify our
findings on fall risk associated with cueing over longer periods. In
addition, the cost effectiveness of an extended therapeutic cueing
programme possibly supplemented with a permanent cueing
device needs further investigation. Although most patients
preferred the auditory cueing modality (67%), a large number of
them (33%) perceived somatosensory cueing as a well-tolerated
and discrete alternative. At present, auditory cueing alone can be
provided at relatively low cost using metronomes with earphones
or via digital music players.
We conclude that cueing training in the home situation has a
small and specific benefit for managing gait and freezing in
patients with Parkinson’s disease. In addition, this study has
highlighted important questions on how to deliver cueing
training in the most optimal way.
ACKNOWLEDGEMENTS
We thank the financial support from the European Commission
Framework V funding, QLK6-2001-00120. We also thank the contribu-
tion of Professor Rowena Plant in gaining funding. Prof. ECH Wolters
(MD, PhD), Dr HW Berendse (MD, PhD), CM Zijlmans (MD, PhD), Prof
R Dom (MD, PhD), Dr D Burn (MD) and Dr R Walker (MD) are
acknowledged for referral of patients. We also acknowledge help with
data analysis from S Fieuws and K Desloovere, and, in particular, the
patients with Parkinson’s disease and their carers who participated in
this study.
Authors’ affiliations
. . . . . . . . . . . . . . . . . . . . . . .
A Nieuwboer*, A M Willems, F Chavret, Katholieke Universiteit, Leuven,
Belgium
G Kwakkel*, E van Wegen, I Lim, Vrije Universiteit Medisch Centrum,
Amsterdam, The Netherlands
L Rochester*, D Jones*, V Hetherington, K Baker, Northumbria University,
Newcastle, UK
*These authors contributed equally to this work.
Table 3 Intervention effects and change at follow-up (test 4 2 test 3)
Intervention b
estimate (SE)
Change in units*
(% range) p Value
Follow-up b estimate
(SE) test 4-test 3 p Value
Primary outcomes
PG score (0–20) q20.85 (0.3) 4.2% 0.005 Q0.582 (0.14) ,0.001
Secondary outcomes
Gait and Balance
Speed (m/s) q0.05 (0.02) 5 cm/s* 0.005 Q20.02 (0.007) 0.03
Step length (m) q0.04 (0.009) 4 cm* 0.001 Q20.02 (0.004) ,0.001
Step frequency (steps/min) q22.1 (1.19) 22.1 steps/min* 0.08 Q1.24 (0.56) 0.03
Functional reach (cm) q1.3 (0.97) 1.3 cm* 0.18 Q21.08 (0.46) 0.02
Tandem stance (s) – – – – –
Single leg stance (s) – – – – –
TGUG (s) q20.002 (0.73) 2 ms 0.6 Q0.14 (0.2) 0.47
FOGQ (0–24) q20.86 (0.44) 3.6% 0.25` Q0.8 (0.21) 0.001
Activity
NEADL (0–66) q1.71 (0.94) 2.6% 0.07 Q20.65 (0.5) 0.2
FES (0–130) q4.77 (2.29) 3.7% 0.04 Q22.92 (1.22) 0.02
Participation
PDQ-39 (total%) q21.36 (1.14) 1.4% 0.23 Q0.99 (0.52) 0.06
CSI (0–13) q20.76 (0.32) 5.8% 0.14` Q0.15 (0.18) 0.42
CSI, Carer Strain Index; FES, Falls Efficacy Scale; FOGQ, Freezing Of Gait Questionnaire; NEADL, Nottingham Extended ADL Index; PDQ-39, Parkinson’s Disease
Questionnaire; PG score, posture and gait score; TGUG, Timed Get Up and Go test.
qEstimate represents change in direction of improvement.
QEstimate represents change in direction of deterioration.
*Change expressed as measured units, positive figures represent an improvement
Change expressed as % of the scoring range; positive figures represent an improvement.
`After transformation.
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